Clinical Trial Update: Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Zylet (tobramycin + loteprednol etabonate) to Lotemax, tobramycin, and vehicle in pediatric blepharoconjunctivitis assessed s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conjunctivitis

Drugs mentioned

• Lotemax (Loteprednol etabonate)
• TOBRAMYCIN (Tobramycin)
• Zylet (loteprednol etabonate and tobramycin)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Conjunctivitis | Phase 4 | Status: COMPLETED | Results posted: 2011-08-11